ESMO: European Society for Medical Oncology

  1. It is intended for the treatment of patients whose solid tumours have NTRK gene fusion or for patients with ROS1-positive advanced NSCLC

  2. Results of the UK Coronavirus Cancer Monitoring Project 

  3. Results from a phase II trial

  4. New indication concerns maintenance treatment of metastatic adenocarcinoma of the pancreas with germline BRCA1/2-mutations 

  5. Alpelisib is intended for the treatment of advanced breast cancer with a PIK3CA mutation